Partnerships

Seeking partners to advance our drug discovery and development efforts


To feed our pipeline and maximize the potential for our development programs, we are seeking both to “partner in” and “partner out.” Specifically, we are looking for:

  • In-licensing opportunities and research collaborations for small molecule programs to feed our pipeline of programs that we will move into development
  • Development and commercialization partners for our pipeline programs once they have reached an appropriate stage

Our recent partnerships include:

  • A worldwide license agreement with Roche for a VAP-1 inhibitor discovered by the team at Proximagen and moved into Phase II development. Proximagen and Upsher-Smith will collaborate with Roche to conduct further Phase II trials on this molecule.
    View Press Release
  • A research collaboration with Saniona to identify candidate drugs acting on an ion channel drug target implicated in pain and other neurological disorders.
    View Press Release